Januvia is promoted by its manufacturer Merck as a once-daily prescription pill that helps adults with type-2 diabetes lower their blood sugar levels. In September 2009, the FDA revised the prescribing information for Januvia and alerted healthcare professionals to monitor diabetic patients taking this medication for signs of pancreatitis. Januvia is generically known as sitagliptin.
Merck allegedly failed to adequately test Januvia and failed to provide adequate risk information to the FDA, healthcare professionals, and patients.
Manufactured by Novo Nordisk, Victoza is a once-daily injection for the treatment of type-2 diabetes in adults to help lower blood sugar levels, along with diet and exercise. It is generically known as liraglutide.
The use of Victoza is associated with the risk of pancreatitis, as well as the risk of medullary thyroid cancer. The FDA is requiring Novo Nordisk to conduct a five-year epidemiological study and to create a medullary thyroid cancer registry to monitor cases related to Victoza use.
Janumet (sitagliptin and metformin)
Janumet, manufactured by Merck, is a prescription medication in tablet form that has been prescribed for use along with diet and exercise to lower blood sugar in adults with type-2 diabetes. Janumet contains both sitagliptin and metformin.
Byetta is an injectable prescription medicine that can help control blood sugar levels in adults with type-2 diabetes, in conjunction with diet and exercise. The manufacturer, Amylin Pharmaceuticals, markets Byetta as capable of lowering blood sugar levels and being safe to prescribe with other diabetic medications. Byetta is generically known as exenatide.
It has been alleged that Amylin Pharmaceuticals failed to test Byetta properly before bringing it to market and then failed to provide adequate information to the FDA about the drug’s risks. Learn more about the FDA’s warnings about Byettta.
If you or someone you love have experienced negative side effects from any of these drugs, call Alexander Shunnarah Personal Injury Attorneys today at 1-800-229-7989.